Terminated PHASE3 INTERVENTIONAL 2-arm NCT01192594

Milestones of Adjustment Post-Psychosis (MAPP)

Outcomes of Psychiatric Case Manager Training on Medication Adherence, Progression Through the Four Phases of the MAPP Recovery Model, and Quality of Life in Patients With Schizophrenia

Sponsor: Yale University

Conditions Adjustment, Psychological Medication Adherence Quality of Life Schizophrenia Signs and Symptoms

Interventions Training in all modules except MAPP Recovery Model Training in all modules including MAPP Recovery Model

Updated 5 times since 2017 Last updated: Sep 6, 2016 Started: Nov 30, 2009 Primary completion: Jan 31, 2013 Completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Yale University

See all terminations from Yale University

A PHASE3 clinical study on Adjustment, Psychological and Medication Adherence, this trial is terminated or withdrawn. The trial is conducted by Yale University and has accumulated 5 data snapshots since 2009. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Nov 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Yale University

Data source: Yale University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Haven, United States